SCHEMBL572346

SCHEMBL572346

NC(=O)[C@H]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL240170 1.00
SCHEMBL221055 1.00
Bromide SCHEMBL7327552 0.98 GLI1 (0.59)
Hydrochloric Acid SCHEMBL6976932 0.98 GLI1 (0.59)
Hydrochloric Acid SCHEMBL30937515 0.98
Hydrochloric Acid SCHEMBL25236164 0.98 GLI1 (0.59)
Bromide SCHEMBL7327555 0.98 GLI1 (0.59)
Hydrochloric Acid SCHEMBL4316344 0.98
Hydrochloric Acid SCHEMBL241228 0.98
Hydrochloric Acid SCHEMBL241227 0.98

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4605407-A2 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS Endevica Bio, Inc. (US) 2025-08-27 EP claimed
WO-2024086381-A2 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS ENDEVICA BIO, INC. (US) 2024-04-25 WO claimed
US-20240025949-A1 Beta-Arrestin Effectors and Compositions and Methods of Use Thereof TREVENA, INC. 2024-01-25 US claimed
CN-116693439-A Synthesis method of (R) -N-methyl-1- (pyrrolidine-2-yl) methylamine 南通敏言生物医药科技有限公司 2023-09-05 CN claimed
CN-116606235-A Synthesis method of (R) - (1-methylpyrrolidine-2-yl) methylamine dihydrochloride 南通敏言生物医药科技有限公司 2023-08-18 CN claimed
CN-111601798-B Bisamide sarcomere activating compounds and uses thereof 美国安进公司 2023-08-11 CN claimed
CN-110240631-B Chiral isoindolone cyclopeptide derivative, preparation method and application thereof 哈尔滨师范大学 2023-02-17 CN claimed
CN-114436925-A M-diphenyl phenol ether compound and its preparation method and use 河北大学 2022-05-06 CN claimed
CN-110702820-B HPLC method for separating absinthin A, B 南京泓纬医药科技有限公司 2022-05-03 CN claimed
EP-2772476-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL HAMARI CHEMICALS LTD (JP) 2017-01-11 EP claimed
EP-1615921-A2 PYRIDO 2,3-D PYRIMIDIN-7-CARBOXYLIC ACID DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2006-01-18 EP claimed
WO-2005090344-A1 NOVEL DICHLORO-PHENYL-PYRIDO [2,3-D] PYRIMIDINE DERIVATES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2005-09-29 WO claimed
US-20050130984-A1 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents F. HOFFMANN-LA ROCHE AG (DE) 2005-06-16 US claimed
EP-0929553-B1 PYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2005-03-16 EP claimed
WO-2004085436-A2 PYRIDO[2,3-D]PYRIMIDIN-7-CARBOXYLIC ACID DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2004-10-07 WO claimed
US-6599902-B2 For treating or preventing a protein kinase related disorder SUGEN, INC. 2003-07-29 US claimed
US-6251911-B1 Pyrimidine derivatives and processes for the preparation thereof NOVARTIS AG (CH) 2001-06-26 US claimed
EP-0929553-A1 PYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1999-07-21 EP claimed
WO-1998014450-A1 PYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 1998-04-09 WO claimed
US-5688913-A OLIGOPEPTIDES AS ANTIINFLAMMATORY AGENTS CYTEL CORPORATION (US) 1997-11-18 US claimed